ChristopherHooperGossMD
Pulmonology • Seattle, WAPleural Disease
Professor, Medicine and Pediatrics, University of Washington School of Medicine
Dr. Goss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4615Fax+1 206-598-7214- Is this information wrong?
Education & Training
University of WashingtonFellowship, Critical Care Medicine (Internal Medicine), 2001
University of California (San Francisco)Residency, Internal Medicine, 1992 - 1995
University of Colorado School of Medicine Anschutz Medical CampusClass of 1992
Certifications & Licensure
WA State Medical License 1997 - 2024- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis Start of enrollment: 2009 Jan 01
- A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients Start of enrollment: 2010 Apr 01
- Early Intervention in Cystic Fibrosis Exacerbation Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.Jordana E Hoppe, Jacquelyn Sjoberg, Gina Hong, Katie Poch, Edith T Zemanick, Stephanie Thee, Claire Edmondson, Dhiren Patel, Meghana Sathe, Drucy Borowitz, Melissa S P...> ;Journal of Cystic Fibrosis. 2024 Feb 29
- Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries.Calthorpe, R., Rosenfeld, M., Carr, S., Smyth, A., Stewart, I., Goss, C., Green, N., Derleth, M.> ;Journal of Cystic Fibrosis. 2024 Feb 10
- Qualitative Analysis of Perspectives on Lung Transplant among People with Cystic Fibrosis.Hobler, M., Bartlett, L., Gill, E., Engelberg, R., Curtis, J., Hartzler, A., Smith, P., Milinic, T., Burdis, N., Aitken, M., Kapnadak, S., Goss, C., Ramos, K.> ;Annals of the American Thoracic Society. 2024 Jan 23
- Join now to see all
Press Mentions
- The Association Between Heroin Inhalation and Early Onset EmphysemaJuly 17th, 2020
Using 1 Germ to Fight Another When Today’s Antibiotics FailFebruary 26th, 2019
New Approach Against Antibiotic-Resistant Bacteria in CF Patients Shows Promise in Phase 1 TrialOctober 9th, 2018- Join now to see all
Grant Support
- Early Intervention In Pulmonary Exacerbation In CFNational Heart, Lung, And Blood Institute2010–2011
- A Pharmacokinetic And Safety Study Of IV Gallium Nitrate (GANITE) In Cystic FibroFood And Drug Administration2009–2010
- Environmental Effects On Lung Function In Cystic Fibrosis PatientsNational Institute Of Environmental Health Sciences2007–2008
- CF Respiratory Symptom QuestionnaireNational Center For Research Resources2007
- Quality Of Life In Adults And Adolescents With Severe Cystic FibrosisNational Center For Research Resources2004–2007
- Quality Of Life In Adolescents With Severe Cystic FibrosisNational Center For Research Resources2004–2007
- Quality Of Life In Patients With Severe Cystic FibrosisNational Heart, Lung, And Blood Institute2003–2007
- Study Of Orally Administered Curcuminoids In Adult Subjects With Cystic FibrosisNational Center For Research Resources2006
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
